Division of Pathogenic Biochemistry
Staff Research Publication  
     

List of Publications

≪ Previous Year 2016 Next Year ≫

Books and Reviews

Original Papers

1) Hayashi M., Kai C., Matsuda A., Naoe T., Ohtsu A, Okazaki T, Saji H., Sata M., Sugimura H., Sugiyama Y., Toi M. and Irimura T.: Report, Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs, Cancer Sci. 107: 189-202, 2016.[Abstract]
2) Lou C., Yokoyama S., Abdelhamed S., Saiki I. and Hayakawa Y.: Targeting ATM pathway for effective therapy against hirsutine-resistant breast cancer cells. Oncology Lett., 12(1): 295-300, 2016.[Abstract]
3) Sasaki S., Baba T., Nishimura T., Hayakawa Y., Hashimoto S.I., Gotoh N. and Mukaida N.: Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis. Cancer Lett., 378(1): 23-32, 2016..[Abstract]
4) Matsuo K., Koizumi K., Fujita M., Morikawa T., Jo M., Shibahara N., Saiki I., Yoshie O. and Nakayama T.: Efficient use of a crude drug/herb library reveals Ephedra Herb as a specific antagonist for TH2-specific chemokine receptors CCR3, CCR4, and CCR8. Front. Cell Dev. Biol. (Cell Adhesion and Migration), doi: 10.3389/fcell.2016.00054.
5) Abdelhamed, S., Ogura, K., Yokoyama, S., Saiki, I. and Hayakawa, Y.: AKT-STAT3 pathway as a downstream target of EGFR signaling to regulate PD-L1 expression on NSCLC cells. J. Cancer 7(12), 1579-1586, 2016.[Abstract]
6) Kimura Y., Nagai N., Tsunekawa N., Sato-Matsushita M., Yoshimoto T., Cua D., Iwakura Y., Yagita H., Okada F., Tahara H., Saiki I., Irimura T. and Hayakawa Y.: IL-17A-producing CD30+ Vδ1 T cells drive inflammation-induced cancer progression. Cancer Sci., in press, 2016..[Abstract]
7) Kato S., Yokoyama S., Hayakawa Y., Li, L., Iwakami Y., Sakurai H. and Saiki I.: p38 Pathway as a key downsream signal of CTGF to regulate metastatic potential of NSCLC. Cancer Sci.,1416-1421., 2016.[Abstract]
8)
9)
10)
11)
12)
13)
14)
15)
16)
17)
18)
19)
20)

▲Page top

 
Top page Study for cross roads of between natural medicine and cancer research
Division of Pathogenic Biochemistry
Institute of Natural Medicine, University of Toyama
2630 Suginoki, Toyama 930-0194, Japan

Japanese
Top page University of Toyama Institute of Natural Medicine